Financial constraints on genetic counseling and further risk-management decisions among U.S. women at elevated breast cancer risk

J Genet Couns. 2021 Oct;30(5):1452-1467. doi: 10.1002/jgc4.1413. Epub 2021 Mar 21.

Abstract

Clinical guidelines recommend that women at high risk of breast cancer should consider various risk-management options, which remain widely underutilized. We conducted semi-structured, qualitative interviews with 50 high-risk women to understand how financial constraints affect use of genetic counseling, genetic testing, and further risk-management decisions. Inductive analyses revealed three categories of health-related financial constraint: (a) lack of insurance, (b) underinsurance, and (c) other financial constraints (e.g., medical debt, raising children, managing comorbidities). Various breast cancer risk-management actions were limited by these financial constraints, including genetic counseling, genetic testing, enhanced screening, and prophylactic surgeries. Women's narratives also identified complex relationships between financial constraint and perceptions of healthcare providers and insurance companies, particularly as related to bias, price transparency, and potential genetic discrimination. Results from this study have implications for further research and expansion of genetic counseling services delivery to more economically and racially diverse women.

Keywords: decision-making; disparities; health behavior; lived experience; risk management.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Breast Neoplasms* / genetics
  • Child
  • Decision Making
  • Female
  • Genetic Counseling*
  • Genetic Testing
  • Humans
  • Risk
  • Risk Management